Chemical space
Chemical space is vast. Estimates range from 10180 for compounds with molecular weights less than 500 to 1060 for drug-like structures. Estimates suggest that using the default fragment set, SkelGen is capable of working within a space of 1014 structures. This number is many orders of magnitude larger than 106 compounds that are routinely used in HTS. Therefore
  • using in silico techniques allows exploration of a greater amount of chemical space

  • exploring this extra space makes it easier to find novel, patentable structures

  • using in silico techniques means we can design lower molecular weight compounds that are needed for further optimisation.

Print this page

 
Recent News
De Novo Agrees Med Chem Synthesis Deal
De Novo Launches Academic Access Programme
De Novo Takes SkelGen to Japan
De Novo Launches ‘Stand-Alone; SkelGen
De Novo signs first academic licence with the University of Hertfordshire
De Novo Pharmaceuticals announces a Drug Discovery Partnership agreement with Achaogen
De Novo Pharmaceuticals Ltd. Announces New Partnering Opportunity in Diabetes
De Novo Pharmaceuticals Ltd. Announces New Therapeutic Focus In the Area Of Metabolic Diseases And Appoints New Scientific Advisory Board.
De Novo Pharmaceuticals Ltd Announces Drug Discovery Collaboration Agreement with Genzyme
De Novo launches Reflex, a major upgrade to its in silico drug design platform